The Prognosis and Predictive Value of Estrogen Negative/Progesterone Positive (ER−/PR+) Phenotype: Experience of 1159 Primary Breast Cancer from a Single Institute

Figure 5

Relation among 5-ER−/PR+/HER2−, 6-ER−/PR+/HER2+, 1-ER+/PR any, 3-TNBC, and 4-HER2+ and disease-free interval in the whole series; (b) relation among 5-ER−/PR+/HER2−, 6-ER−/PR+/HER2+, 1-ER+/PR any, 3-TNBC, and 4-HER2+ and overall survival in the whole series.